| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.12 | 0.4 |